TopBuild Corp.
BLD
$354.53
-1.45%
TopBuild Corp. is a leading installer and distributor of insulation and other building products, operating through two segments: Installation Services, which installs insulation, commercial roofing, glass, windows, and gutters primarily in the residential new-construction market, and Specialty Distribution, which distributes insulation and related materials to residential, commercial, and industrial customers, with the bulk of revenue generated in the U.S. and a smaller footprint in Canada. The company is the largest player in its niche, holding a scale-driven leadership position in insulation installation and distribution that gives it purchasing leverage, national builder relationships, and a reputation as a consolidator of a highly fragmented contractor landscape. The dominant investor narrative right now is the pending $17 billion acquisition by QXO, announced in April 2026, which has transformed BLD into a merger-arbitrage vehicle and reframed the debate around deal spread, cash-and-stock consideration, and integration risk rather than standalone fundamentals. This deal overhang, layered on top of a softening residential construction backdrop and a sharp late-June share-price drawdown, explains why the stock has decoupled from a still-positive one-year return and why analyst attention has shifted toward deal mechanics and the strategic merits of combining TopBuild with QXO's building-products platform.…
BLD
TopBuild Corp.
$354.53
Related headlines
Investment Opinion: Should I buy BLD Today?
Rating: Hold (merger-arbitrage / event-driven, not a standalone fundamental Buy). The core thesis is that BLD at $354.53 is no longer priced on its own earnings power but on the probability-weighted outcome of QXO's $17 billion cash-and-stock acquisition announced in April 2026, and with the stock only 10.2% above its $321.67 52-week low and 15.08% down over the past month, the risk/reward is binary rather than fundamentally anchored. Analyst sentiment is constructive but thin — three of the recurring firms (DA Davidson, RBC, Benchmark) carry Buy/Overweight versus two at Sector Perform/In Line — yet no discrete average price target is available in the dataset, so implied upside cannot be computed and the consensus EPS of $23.77 (range $23.23–$24.14, a sub-4% spread) is the only high-conviction anchor.
Supporting evidence is mixed. On the positive side, Q4 2025 revenue grew 13.19% year-over-year to $1.485 billion, TTM free cash flow is a robust $696.9 million with roughly 90% conversion from operating cash flow, ROE stands at 22.53%, and the forward PE of 17.01x sits well below the trailing 22.69x, implying expected earnings growth. Against that, gross margin compressed 260 basis points year-over-year to 27.24% (from 29.88%), operating margin fell to 12.10% from 16.57%, net income dropped 30.6% to $104.5 million, and interest expense more than doubled to $38.2 million as debt-to-equity climbed to 1.36 from 0.71. The EV/EBITDA of 13.48x and price-to-book of 5.03x reflect a moderate premium that is increasingly hard to defend against the margin and leverage trends.
The biggest risks that could invalidate the thesis are (1) a broken or renegotiated QXO deal, which would strip out the arbitrage support and expose the standalone margin deterioration, (2) continued gross-margin erosion below the 27% level, and (3) a housing/rate-driven demand downturn amplified by the 1.807 beta. This Hold would upgrade to Buy on deal confirmation at the announced terms or a reclaim of the $400–$425 technical shelf, and would downgrade to Sell on a deal termination or a break below the $321.67 52-week low. On valuation, BLD is neither a clear historical bargain nor obviously overvalued — the 22.69x trailing PE sits in the upper-middle of its 8.6x–28.8x historical band, while the 2.15x price-to-sales is near the low end of its multi-year range — so the stock is best characterized as fairly valued on fundamentals but event-driven on deal mechanics.
Sign up to view all
BLD 12-Month Price Forecast
BLD is best framed as an event-driven merger-arbitrage situation rather than a standalone fundamental story, with the $17 billion QXO acquisition dominating price discovery. The fundamental backdrop is deteriorating — 260 bps of gross-margin compression, a 30.6% net income decline, and debt-to-equity doubling to 1.36 — but strong $696.9 million TTM free cash flow and a 17.01x forward PE provide a valuation floor if the deal holds. Analyst coverage is thin (two contributors, no discrete price target) and in a holding pattern since March 2026, which limits conviction and raises the potential for headline-driven volatility given the 1.807 beta. The probability-weighted setup (30% bull / 50% base / 20% bear) supports a neutral stance: the base case keeps the stock range-bound between the 52-week low and the $400–$425 shelf. I would upgrade to bullish on confirmed deal clearance at announced terms or a reclaim of $400–$425, and downgrade to bearish on deal termination or a decisive break below $321.67.
Wall Street consensus
Coverage of TopBuild is thin, with only 2 analysts contributing to the consensus estimate dataset, and the provided institutional ratings history shows a small but engaged group of firms — DA Davidson, RBC Capital, Benchmark, Wells Fargo, Evercore ISI, and Jefferies — that have largely maintained their ratings (Buy/Overweight/Sector Perform/In Line) without recent upgrades or downgrades, indicating a stable but cautious stance. The consensus estimated EPS averages $23.77 (range $23.23 to $24.14) on estimated revenue of approximately $6.74 billion, but the dataset does not provide a discrete average price target, so an implied upside/downside calculation from the current $354.53 price cannot be computed from the available inputs. The tone of the ratings skews constructive — three of the recurring firms carry Buy or Overweight designations versus two at Sector Perform/In Line — but the absence of fresh rating actions since March 2026 suggests analysts are in a holding pattern pending clarity on the QXO transaction. The target range and signal strength cannot be fully assessed because explicit price targets are not included in the provided data, though the tight clustering of EPS estimates ($23.23 to $24.14, a spread of under 4%) signals relatively high conviction on near-term earnings. The more telling signal is the divergence between fundamental estimates and the stock's collapse to $354.53, which implies the market is pricing the QXO deal terms and integration risk rather than the standalone earnings outlook; the high end of any implied valuation would assume deal completion at the announced premium, while the low end would reflect a broken deal or margin deterioration scenario. Given the minimal analyst count and the deal-driven overhang, price discovery is likely less efficient than for a large-cap peer, and investors should treat consensus estimates with caution until the QXO transaction resolves.
Bulls vs Bears: BLD Investment Factors
The bear case currently has stronger evidence, driven by deteriorating margins, rising leverage, and technical weakness, all compounded by the uncertainty surrounding the QXO acquisition. While the bull case rests on the deal premium, strong free cash flow, and market leadership, these positives are overshadowed by the 30.6% net income decline and the stock's proximity to its 52-week low. The single most important tension is whether the QXO deal will close on favorable terms; a successful completion could unlock significant value, but any hiccup or renegotiation could lead to further downside. Investors must weigh the arbitrage opportunity against the risk of a broken deal and continued fundamental erosion.
Bullish
- QXO Acquisition Premium: The pending $17 billion acquisition by QXO, announced in April 2026, offers shareholders a premium cash-and-stock consideration. This deal has transformed BLD into a merger-arbitrage vehicle, with the stock trading at $354.53, well below the implied deal value, suggesting potential upside if the transaction closes.
- Strong Free Cash Flow Generation: TopBuild generated $696.9 million in trailing twelve-month free cash flow, with a healthy FCF-to-operating-cash-flow conversion ratio of about 90%. This robust cash generation provides financial flexibility and supports the company's ability to fund acquisitions and reduce debt.
- Market Leadership in Insulation: As the largest player in insulation installation and distribution, TopBuild benefits from scale-driven advantages, including purchasing leverage and national builder relationships. The core insulation franchise generated $1.148 billion in Q4 2025 revenue, dominating the segment mix and providing a stable revenue base.
- Revenue Growth Despite Margin Pressure: Q4 2025 revenue grew 13.19% year-over-year to $1.485 billion, continuing a steady top-line expansion through 2025. This growth demonstrates underlying demand and the company's ability to capture market share even in a softening residential construction environment.
Bearish
- Sharp Margin Compression: Q4 2025 gross margin fell to 27.24% from 29.88% a year earlier, a 260-basis-point erosion, while operating margin dropped to 12.10% from 16.57%. Net income declined 30.6% year-over-year to $104.5 million despite higher revenue, highlighting deteriorating profitability.
- Rising Leverage and Interest Burden: Debt-to-equity has surged to 1.36 from 0.71 a year ago, with total debt-to-capitalization at 57.6%. Interest expense jumped to $38.2 million in Q4 2025 from $17.3 million, consuming a larger share of earnings and increasing financial risk.
- Deal Overhang and Uncertainty: The pending QXO acquisition creates significant uncertainty, with the stock trading at $354.53, near the 52-week low of $321.67. The market is pricing in integration risks and potential deal failure, as evidenced by the 16.7% two-day collapse in late June.
- Technical Breakdown and Weak Momentum: BLD is in a damaged downtrend, down 15.08% in the past month and 17.83% year-to-date, trailing the S&P 500 by 13.80 percentage points over one month. The stock sits just 10.2% above its 52-week low, with thin support and a beta of 1.807 amplifying downside risk.
BLD Technical Analysis
BLD is in a damaged intermediate-term downtrend despite a still-positive one-year return of 9.51%, with the stock closing at $354.53 against a 52-week range of $321.67 to $559.47 — placing it at roughly 13.8% of that range, deep in the lower quartile and only about 10.2% above its 52-week low. That positioning signals a stock that has surrendered most of its prior gains and is behaving like a falling knife rather than a momentum leader, with the year-to-date decline of 17.83% underscoring how much ground has been given back since the January peak near $550. The proximity to the 52-week low means downside support is thin and the risk/reward skews toward further capitulation unless a catalyst stabilizes the price. Recent momentum is decisively negative and accelerating: the 1-month change of -15.08% and 3-month change of -3.96% show the selloff intensifying into the end of June, with the final two sessions alone dropping from $425.52 to $354.53 (a roughly 16.7% two-day collapse). This short-term weakness directly contradicts the positive 1-year trend, a classic bearish divergence that typically signals either a trend reversal or a violent mean-reversion event tied to the QXO deal repricing; the 6-month change of -15.02% confirms the deterioration is not a brief blip. Relative strength is uniformly poor, with the stock trailing SPY by 13.80 percentage points over one month and 27.34 points year-to-date, indicating sustained institutional distribution. Key technical levels are the $321.67 52-week low as the critical support floor and the $559.47 52-week high as distant resistance, with the January-February shelf around $480-$550 now acting as overhead supply. A breakdown below $321.67 would confirm a full trend reversal and likely trigger momentum-driven selling, while a reclaim of the $400-$425 area would be the first sign of stabilization. The beta of 1.807 means the stock is roughly 81% more volatile than the market, so position sizing should account for amplified drawdowns — consistent with the reported max drawdown of -39.12% — and the short ratio of 3.28 suggests moderate short interest that could fuel sharp squeezes on any deal-related headline.
Beta
1.81
1.81x market volatility
Max Drawdown
-39.1%
Largest decline past year
52-Week Range
$322-$559
Price range past year
Annual Return
+9.5%
Cumulative gain past year
| Period | BLD Return | S&P 500 |
|---|---|---|
| 1m | -15.1% | -1.3% |
| 3m | -4.0% | +14.0% |
| 6m | -15.0% | +9.5% |
| 1y | +9.5% | +20.9% |
| ytd | -17.8% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BLD Fundamental Analysis
TopBuild's revenue trajectory remains in growth mode but with clear deceleration in profitability quality: the most recent quarter (Q4 2025) posted revenue of $1.485 billion with 13.19% year-over-year growth, yet this came against a sequential cadence of $1.233 billion (Q1), $1.297 billion (Q2), and $1.393 billion (Q3), showing steady top-line expansion through 2025. However, the year-over-year comparison reveals margin pressure — Q4 2025 revenue of $1.485 billion exceeded Q4 2024's $1.312 billion, but net income fell to $104.5 million from $150.5 million, a 30.6% decline despite the higher sales base. Within the mix, insulation and accessories dominate at $1.148 billion of segment revenue, dwarfing gutters ($75.5 million), glass and windows ($56.9 million), and all other ($110.6 million), meaning the core insulation franchise is the swing factor for the entire growth story. The takeaway is a company still growing revenue but increasingly challenged to convert that growth into earnings, a dynamic that likely informed the strategic decision to sell to QXO. Profitability is solid in absolute terms but compressing meaningfully: Q4 2025 gross margin of 27.24% compares unfavorably to 29.88% in Q4 2024 and 30.30% in Q3 2025, a roughly 260-basis-point year-over-year erosion, while the operating margin of 12.10% and net margin of 7.04% both trail the prior-year quarter's 16.57% operating and 11.47% net margins. Net income of $104.5 million on $1.485 billion of revenue marks a sharp step down from the $142.2 million earned in Q3 2025 and the $150.5 million in Q4 2024, reflecting both gross-margin compression and a jump in interest expense to $38.2 million from $17.3 million a year earlier — a direct consequence of debt taken on for acquisitions. The trailing gross margin of 29.01% and operating margin of 14.64% remain respectable for a construction-installation business, but the directional trend is clearly negative, and the effective tax rate near 27% offers little cushion. Balance sheet health is adequate but leverage has risen materially: debt-to-equity stands at 1.36, up sharply from 0.71 a year earlier, and total debt-to-capitalization is 57.6%, reflecting the debt-funded acquisition spree that saw $1.08 billion of acquisitions in Q4 2025 alone. Free cash flow remains a genuine strength at $696.9 million TTM, with Q4 2025 FCF of $159.4 million and a healthy FCF-to-operating-cash-flow conversion ratio of about 90%, while the current ratio of 1.94 and ROE of 22.53% confirm the business still generates robust returns and has ample short-term liquidity. That said, the cash-flow-to-debt ratio of just 0.056 and interest coverage of 4.70x highlight that the leveraged balance sheet now consumes a meaningful share of cash flow, and the $957.7 million net cash decline in Q4 2025 (driven by the acquisition outlay) shows the company is dependent on external capital to fund its consolidation strategy rather than purely self-funding growth.
Quarterly Revenue
$1.4B
2026-04
Revenue YoY Growth
+17.2%
YoY Comparison
Gross Margin
27.7%
Latest Quarter
Free Cash Flow
$704431000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BLD Overvalued?
Because TopBuild is profitable — Q4 2025 net income of $104.5 million and positive trailing earnings — the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 22.69x against a forward PE of 17.01x. The roughly 25% compression between trailing and forward multiples implies the market expects meaningful earnings growth ahead, though this expectation is complicated by the pending QXO deal, which may render standalone forward estimates less relevant as the stock increasingly trades on deal terms rather than fundamental earnings power. The PEG ratio of -2.29 is not analytically meaningful here given distorted growth inputs and should be disregarded. On peer comparison, BLD's trailing PE of 22.69x and price-to-sales of 2.15x sit against an engineering and construction industry where the provided valuation dataset does not supply a clean sector-average multiple, so a precise premium/discount spread cannot be quantified from the available data; however, the EV/EBITDA of 13.48x and price-to-book of 5.03x suggest the stock is priced at a moderate premium consistent with its market-leading position and historically superior returns on equity (22.53%). The forward PE of 17.01x is more reasonable and, if achieved, would represent a discount to the trailing multiple that could be justified by the company's scale advantages and FCF generation — but the margin compression trend and rising leverage argue that any premium is now harder to defend than it was a year ago. Historical context is instructive: BLD's PE ratio has ranged from roughly 8.6x in late 2022 to 28.8x at the end of 2021, and the current 22.69x sits in the upper-middle portion of that band, well above the 15-18x levels seen through much of 2024 but below the 2021 peak. The price-to-sales ratio of 2.15x, by contrast, is near the low end of its multi-year range (which stretched above 10x in 2021-2024 on the historical series), reflecting the recent price collapse rather than fundamental deterioration alone. This mixed picture — elevated PE but depressed PS — suggests the market is pricing in earnings risk and deal uncertainty, and the stock is neither a clear historical bargain nor obviously overvalued on its own trading history.
PE
22.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~29x
vs. Industry Avg
32.2x
Industry PE ~32.2x*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
TopBuild faces mounting financial and operational risks. The company's debt-to-equity ratio has risen to 1.36 from 0.71 a year earlier, with total debt-to-capitalization at 57.6%, largely due to debt-funded acquisitions totaling $1.08 billion in Q4 2025 alone. Interest expense more than doubled to $38.2 million in Q4 2025, and the cash-flow-to-debt ratio of just 0.056 and interest coverage of 4.70x indicate that the leveraged balance sheet now consumes a meaningful share of cash flow. Additionally, margin compression is evident: gross margin fell 260 basis points year-over-year to 27.24%, and net income declined 30.6% despite a 13.19% revenue increase, highlighting operational challenges. Revenue concentration in insulation (77% of segment revenue) adds risk if demand in residential new construction softens further.
Market and competitive risks are significant. The stock's beta of 1.807 means it is roughly 81% more volatile than the market, amplifying drawdowns; the max drawdown has been -39.12%. Valuation compression risk is elevated as the trailing PE of 22.69x sits in the upper-middle of its historical range (8.6x to 28.8x), while the forward PE of 17.01x may be optimistic given margin pressures. The pending QXO acquisition introduces deal-specific risk: integration challenges, potential dilution from stock consideration, and regulatory hurdles could derail the transaction. Recent news highlights concerns about profitability and integration risks, with some analysts suggesting competitor IBP as a safer alternative. Macro sensitivity to residential construction cycles and interest rates further compounds the risk.
The worst-case scenario involves a combination of a broken QXO deal, continued margin deterioration, and a housing market downturn. In this scenario, the stock could retest its 52-week low of $321.67, representing a 9.3% decline from the current price of $354.53. A more severe outcome, such as a recession-driven decline in construction activity and a failed deal, could push the stock below $300, implying a downside of 15-20%. The historical max drawdown of -39.12% suggests that in a stress scenario, losses could exceed 30% from current levels. Investors should consider these downside risks carefully, especially given the stock's high volatility and the binary nature of the pending acquisition.
FAQ
The most severe risk is deal-specific: the $17 billion QXO acquisition could be terminated or renegotiated on financing, regulatory, or integration concerns, which would remove arbitrage support and force a repricing on deteriorating standalone fundamentals. Second is financial risk — debt-to-equity has risen to 1.36 from 0.71, interest expense more than doubled to $38.2 million in Q4 2025, and the cash-flow-to-debt ratio of 0.056 with 4.70x interest coverage leaves limited flexibility if the deal fails. Third is operational: gross margin compressed 260 bps to 27.24% and net income fell 30.6% despite 13.19% revenue growth, with 77% of segment revenue concentrated in insulation. Fourth is macro/technical: a 1.807 beta amplifies housing and rate-driven downturns, and the stock is already down 17.83% year-to-date and 27.34 points behind SPY, with thin support just above the $321.67 low.
The probability-weighted forecast is 30% bull, 50% base, and 20% bear. The base case (50%) keeps the stock range-bound between $340 and $400 as the deal proceeds without material renegotiation and earnings hold near the $23.77 consensus EPS, with margin pressure stabilizing but not reversing. The bull case (30%) targets $430–$480 if the QXO deal closes on announced terms, the spread compresses toward zero, and Fed rate cuts revive residential construction demand. The bear case (20%) targets $280–$322 if the deal is terminated or renegotiated, gross margin falls below 27%, and a housing downturn amplifies the high beta. The base case is most likely, and its key assumption is that the QXO transaction closes broadly on terms while gross margin stabilizes near 27–29%.
BLD's valuation is mixed rather than clearly cheap or expensive. The trailing PE of 22.69x sits in the upper-middle of its historical 8.6x–28.8x band, while the forward PE of 17.01x implies roughly 25% earnings growth that is complicated by the deal overhang. On the other side, the price-to-sales of 2.15x is near the low end of its multi-year range, reflecting the recent price collapse more than fundamental deterioration. The EV/EBITDA of 13.48x and price-to-book of 5.03x suggest a moderate premium consistent with market leadership and a 22.53% ROE. Net, the market appears to be paying a fair-to-slightly-premium price on earnings but a discounted price on sales, implying it expects margin risk and deal uncertainty to persist. The PEG ratio of -2.29 is distorted and should be disregarded.
From a risk/reward standpoint, BLD is a conditional buy at best, and only for investors explicitly seeking merger-arbitrage exposure rather than fundamental value. The stock at $354.53 sits just 10.2% above its $321.67 52-week low and 15.08% below where it traded a month ago, so the market is already pricing meaningful deal risk rather than standalone earnings power. Upside is anchored by the QXO cash-and-stock consideration and the $400–$425 overhead shelf, while downside is defined by the 52-week low and a stress case toward the $280s. The biggest risk is a broken or renegotiated deal, which would expose the 260 bps gross-margin compression and 30.6% net income decline with no arbitrage cushion. It is a reasonable buy for event-driven investors who can tolerate a 1.807 beta and binary outcomes, but a poor fit for anyone seeking a clean fundamental growth story.
BLD is currently better suited to a short-to-medium-term, event-driven horizon than a multi-year buy-and-hold. The pending QXO acquisition makes the outcome binary and time-bound, so the relevant holding period is tied to the deal timeline — roughly the next two to four quarters — rather than to a multi-year compounding thesis. The 1.807 beta, -39.12% max drawdown, and 15.08% one-month decline argue against large, passive positions, while the 0% dividend yield offers no income to compensate for waiting. A long-term investor would need conviction that the combined QXO entity creates durable value and that margin compression reverses, which is not yet evidenced. A concrete suggested minimum holding period is six to twelve months, sized small enough to absorb a retest of the $321.67 low.

